1 - 12 of 98 results
person stepping on scale
1 CME CREDIT

Managing Obesity in Primary Care Practice

1.00 CME/MOC
1.00 AANP | 0.33 Pharmacology

Obesity is the most prevalent chronic disease of the modern era in the U.S. and around the world, affecting both the adult and pediatric population. Although many believe that helping patients to achieve a healthy weight is of minimal complexity, weight regulation and management is a challenging endeavor. In this talk, Dr. Cody Stanford will explore the complexities of obesity and offer a range of strategies (behavioral, therapeutic, and surgical) to help you in the quest to address overweight and obesity in your practice.


Tile overview image
1 CME CREDIT

PCPs stand on the frontlines of obesity management but often do not optimally provide the comprehensive and long-term care these patients require. Bias toward people with obesity can cloud clinical judgement, and comorbidities can take priority over addressing obesity. This expert-led session focuses on obesity as a serious, chronic illness and acknowledges intrinsic and extrinsic biases that negatively affect clinical judgment and relationships with patients. Clinicians will walk away with evidence-based strategies for obesity treatment that includes lifestyle interventions and long-term use of anti-obesity medications as indicated by recent guidelines. Finally, clinicians will hear about emerging treatment options that will likely expand their armamentarium


Tile overview image
1 CME CREDIT

PCPs stand on the frontlines of obesity management but often do not optimally provide the comprehensive and long-term care these patients require. Bias toward people with obesity can cloud clinical judgement, and comorbidities can take priority over addressing obesity. This expert-led session focuses on obesity as a serious, chronic illness and acknowledges intrinsic and extrinsic biases that negatively affect clinical judgment and relationships with patients. Clinicians will walk away with evidence-based strategies for obesity treatment that includes lifestyle interventions and long-term use of anti-obesity medications as indicated by recent guidelines. Finally, clinicians will hear about emerging treatment options that will likely expand their armamentarium


doctor reviewing a chart with patient
1 CME CREDIT

Given that 9 out of 10 people with diabetes also suffer from overweight or obesity, it is important for PCPs to take a holistic approach to treatment rather than solely a glucocentric approach. This activity helps you understand the benefits of weight loss as a key therapeutic strategy in the treatment of type 2 diabetes mellitus (T2DM) and the importance of early treatment intensification to improve long-term outcomes. You’ll also walk away from this session with a firm grasp of the role incretins play in the pathophysiology of T2DM, obesity, and other metabolic conditions and the latest clinical trial evidence behind incretin-based agents.


female doctor talking to her patient
1 CME CREDIT

Obesity & Diabetes: Patient-Centered Clinical Care of African Americans

Episode 3: Bridging the Gap: Conversations with Dr. Hall

1. Review obesity and diabetes trends and health disparities in the US 2. Review body image and perception differences by race/ethnicity 3. Describe best practices in the treatment of diabetes in African Americans 4. Examine the difference in HbA1c interpretations in African Americans and related clinical considerations


person stepping on scale
0.5 CME CREDIT

Addressing “Diabesity”: Weight Loss as a Key Therapeutic Goal in the Management of T2DM (Module 1)

An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.40 AANP | 0.04 Pharmacology


man taking sample for testing
0.5 CME CREDIT

The Role of GIP and GLP-1 in the Pathophysiology of T2DM and Why it Matters (Module 2)

An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.42 AANP | 0.42 Pharmacology


doctors at a speech
0.5 CME CREDIT

Updates From the 2021 EASD and ADA Annual Meetings on Dual GIP/GLP-1 RA Therapy: What You Should Know (Module 3)

An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.40 AANP | 0.40 Pharmacology


Frankly Speaking CME 270
0.25 CME CREDIT

Boosting Weight Loss with Medications: New Support for GLP-1 RAs - Frankly Speaking EP 270

Guest: Jillian Joseph, MSPAS, PA-CMusic Credit: Richard Onorato

0.25 CME

You know GLP-1 RAs are an important class of agents for weight loss, but do you know which drug within this class is right for your patient? This brief podcast walks you through the recent evidence from the STEP 8 randomized clinical trial, comparing the efficacy and adverse reaction profiles for 2 GLP-1 RAs: semaglutide (Wegovy) and liraglutide (Saxenda). This is a must-listen for anyone looking to optimally individualize care for patients with obesity.


Frankly Speaking CME 82

More Than Beauty: Length and Quality of Sleep and Its Impact on CV Risk Factors in Teens - Frankly Speaking EP 82

It has been fairly established that short duration of sleep is associated with obesity in teens and adults; however, the impact of quantity and quality of sleep has not been as well established. A cross-sectional study by Feliciano et al. found that longer and better sleep was associated with better cardiometabolic profiles in early adolescence – independent of other factors. Guest: Susan Feeney, DNP, FNP-BC

It has been fairly established that short duration of sleep is associated with obesity in teens and adults; however, the impact of quantity and quality of sleep has not been as well established. A cross-sectional study by Feliciano et al. found that longer and better sleep was associated with better cardiometabolic profiles in early adolescence – independent of other factors.